[VEGF in therapeutic coronary and peripheral artery angiogenesis]
- PMID: 10372409
[VEGF in therapeutic coronary and peripheral artery angiogenesis]
Abstract
An overview is presented of the various steps of angiogenesis, to which an important contributor is Vascular Endothelial Growth Factor (VEGF), a substance capable of increasing both the permeability and the mitosis rate of endothelial cells. VEGF is also a potent vasodilating agent. The beneficial effects of these properties on the ischemic vasculature have been documented in numerous animal models, leading to the concept of angiogenesis-enhancement as a therapeutic tool. The first clinical trials are under way. This area is discussed based on a literature review.
Similar articles
-
Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.Med Sci Monit. 2000 Sep-Oct;6(5):1047-52. Med Sci Monit. 2000. PMID: 11208453 Review.
-
Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.J Pharmacol Exp Ther. 2001 Dec;299(3):1073-85. J Pharmacol Exp Ther. 2001. PMID: 11714897
-
[The function and application of vascular endothelial growth factor].Sheng Li Ke Xue Jin Zhan. 1996 Jul;27(3):255-7. Sheng Li Ke Xue Jin Zhan. 1996. PMID: 9772368 Review. Chinese. No abstract available.
-
[Vascular endothelial growth factor VEGF stimulates angiogenesis in good and bad situations].Dtsch Med Wochenschr. 1998 Feb 27;123(9):259-65. doi: 10.1055/s-2007-1023947. Dtsch Med Wochenschr. 1998. PMID: 9524537 Review. German. No abstract available.
-
Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF).Vasa. 1998 Nov;27(4):201-6. Vasa. 1998. PMID: 9859738 Review.